Valuation : Guizhou Bailing Group Pharmaceutical Co., Ltd.

Market Cap 6.31B 940M 808M 762M 695M 1.3B 89.84B 1.31B 9.08B 3.49B 45.57B 3.53B 3.45B 145B P/E 2024
193x
P/E 2025 -54.4x
Enterprise Value 7.18B 1.07B 920M 868M 791M 1.48B 102B 1.49B 10.34B 3.98B 51.89B 4.02B 3.93B 165B EV / Sales 2024
1.74x
EV / Sales 2025 2.23x
Free-Float
67.53%
Yield 2024 *
-
Yield 2025 -
1 day-2.12%
1 week+1.09%
Current month+0.43%
1 month+0.65%
3 months+2.21%
6 months-10.81%
Current year+6.21%
1 week 4.58
Extreme 4.58
4.88
1 month 4.44
Extreme 4.44
4.88
Current year 4.08
Extreme 4.08
5.47
1 year 4.08
Extreme 4.08
6.43
3 years 2.98
Extreme 2.98
8.8
5 years 2.98
Extreme 2.98
11.97
10 years 2.98
Extreme 2.98
23.65
Manager TitleAgeSince
Chief Executive Officer 56 02/04/2015
Director of Finance/CFO 41 29/12/2020
Corporate Officer/Principal 42 27/01/2014
Director TitleAgeSince
Chairman 56 27/03/2026
Director/Board Member 58 25/12/2007
Director/Board Member 42 27/01/2014
Date Insider Type Main position Quantity % Market Cap. Importance
21/09/20 Sell

Chairman

1,940,600 0.2495%
18/09/20 Sell

Director

3,670,000 0.4719%
18/09/20 Sell

Chairman

296,500 0.0381%
Change 5-day change 1-year change 3-year change Capi.($)
-2.12%+1.09%-23.64%-39.61% 940M
-0.14%-0.73%-15.19%-4.85% 13.4B
-1.21%-0.67%-32.65%-56.66% 4.84B
-1.26%-3.05%-5.72%-5.01% 4.39B
-1.78%-1.91%-11.02%-29.81% 3.84B
-0.97%-0.08%-1.62%+0.47% 3.5B
-0.62%-2.70%-24.06%+4.95% 3.47B
-1.74%-3.68%-12.93%+5.44% 3.15B
-0.88%-1.35%-22.94%-15.17% 2.3B
-1.10%-0.90%-29.45%-15.19% 1.67B
Average -1.18%-1.98%-17.92%-15.54% 4.15B
Weighted average by Cap. -0.89%-2.09%-16.46%-12.95%

Financials

2024 2025
Net sales 3.83B 570M 490M 463M 421M 788M 54.49B 795M 5.51B 2.12B 27.64B 2.14B 2.09B 87.79B 3.05B 454M 391M 369M 336M 628M 43.43B 633M 4.39B 1.69B 22.03B 1.71B 1.67B 69.97B
Net income 33.62M 5.01M 4.31M 4.07M 3.7M 6.92M 479M 6.99M 48.41M 18.63M 243M 18.81M 18.4M 772M -104M -15.55M -13.37M -12.62M -11.5M -21.49M -1.49B -21.68M -150M -57.84M -754M -58.4M -57.12M -2.4B
Net Debt 1.4B 209M 179M 169M 154M 288M 19.95B 291M 2.02B 776M 10.12B 784M 766M 32.14B 875M 130M 112M 106M 96.34M 180M 12.46B 182M 1.26B 485M 6.32B 489M 479M 20.07B
Logo Guizhou Bailing Group Pharmaceutical Co., Ltd.
Guizhou Bailing Group Pharmaceutical Co Ltd is a China-based company principally engaged in the research and development, production and sales of Miao medicine. The Company operates four segments. The Industrial segment is mainly engaged in the research and development, production and sales of Chinese patent medicine tablets, capsules and syrups. The Commercial segment is mainly engaged in drug distribution and big health business. The Medical Institution segment mainly operates diabetes hospitals. Other segment mainly provides Chinese medicinal materials and are engaged in organic fertilizer manufacturing, water production and supply and other businesses. The Company's products include Yindan Xinnaotong soft capsules, Kesuting syrup and capsules, Shuangyang Houbitong granules and non-Miao medicine products Jingan capsules, Vitamin C Yinqiao tablets, Xiaoer Chaigui antipyretic granules and other products. The Company mainly conducts its businesses in the domestic market.
Employees
5,715
Date Price Change Volume
10/09/26 CN¥4.620 -2.12% 16,262,403
09/09/26 CN¥4.720 +0.43% 8,664,500
08/09/26 CN¥4.700 +1.29% 8,299,103
07/09/26 CN¥4.640 +1.09% 7,604,000
04/09/26 CN¥4.590 +0.44% 4,432,300

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 002424 Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!